USPTO serial 77396174
OPTIMIRA
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- CALLAGHAN, BRIAN P
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with OPTIMIRA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey M. Gitchel
Jeffrey M. Gitchel Bayer Corporation100 Bayer RoadPittsburgh, PA 15205UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry and science, namely, biologically active substances in the nature of proteins and nucleic acids, having affine and/or enzymatic properties, including enzymes and ribozymes; kits comprised of chemical reagents and assays for use in molecular-biological research | ACTIVE | — |
| 005 | Pharmaceutical and veterinary preparations and diagnostic agents, with a base of biologically active substances in the nature of proteins and nucleic acids, all for use in treating autoimmune and inflammation diseases, diseases of blood and lymphatic system, cancer, cardiovascular and circulatory diseases, diseases of the central nervous system, dental diseases, dermatology disorders, diseases of the digestive system, genetic diseases, infections, diseases of the kidney and genitourinary system, metabolic diseases, endocrinology diseases, musculoskeletal disorders, ophthalmology diseases, respiratory and pulmonary diseases, and gynecological diseases; medical diagnostic kits comprised of reagents and assays for testing of samples of a human or animal patient, namely, tissue samples, biopsies, body fluids, smears, skin samples, mucosa samples and hair | ACTIVE | — |
| 042 | Consultancy and contract research in the field of molecular biology, namely, with regard to the development and optimization of biologically active substances; Custom development of biochemical assay systems on a molecular-biological basis, in particular for research, medicine and environmental analytics; scientific research and development in the field of biologically active substances by means of evolutive biotechnology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
- Other trademarks owned by DIREVO BioTech AG
- Other trademarks owned by DIREVO BioTech AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named OPTIMIRA
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 8, 2011 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 8, 2011 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 31, 2011 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 31, 2011 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 14, 2011 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 13, 2011 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Dec 21, 2010 | EXT3 | SOU EXTENSION 3 FILED | — |
| Dec 21, 2010 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 8, 2010 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 7, 2010 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jun 2, 2010 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jun 2, 2010 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 8, 2009 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 8, 2009 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 6, 2009 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 6, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 17, 2009 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 17, 2009 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 16, 2009 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jul 7, 2009 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 25, 2009 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Apr 3, 2009 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Mar 10, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 18, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 2, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 30, 2009 | ALIE | ASSIGNED TO LIE | — |
| Jan 30, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 20, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 19, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 19, 2009 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Oct 27, 2008 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 27, 2008 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 27, 2008 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 17, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 17, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 17, 2008 | ALIE | ASSIGNED TO LIE | — |
| Oct 1, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 30, 2008 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 30, 2008 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 30, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 23, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 20, 2008 | MPMK | NOTICE OF PSEUDO MARK MAILED | — |
| Feb 19, 2008 | NWAP | NEW APPLICATION ENTERED | — |